Journal of Oncology Practice最新文献

筛选
英文 中文
Bridging the Gap: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer. 弥合差距:支持癌症患者共同决策、最大限度延长预约时间和提高患者满意度的优先事项评估工具。
Journal of Oncology Practice Pub Date : 2019-12-09 DOI: 10.1200/JOP.19.00455
M. Frey, Annie E. Ellis, Savannah Shyne, R. Kahn, E. Chapman-Davis, S. Blank
{"title":"Bridging the Gap: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer.","authors":"M. Frey, Annie E. Ellis, Savannah Shyne, R. Kahn, E. Chapman-Davis, S. Blank","doi":"10.1200/JOP.19.00455","DOIUrl":"https://doi.org/10.1200/JOP.19.00455","url":null,"abstract":"PURPOSE\u0000Women with ovarian cancer identify patient-physician communication as an essential element in determining treatment course and believe a discussion about goals and values should precede treatment decisions. We sought to develop a patient-centered priorities assessment tool for women with ovarian cancer that could streamline communication, enhance treatment discussions, and increase patient satisfaction.\u0000\u0000\u0000MATERIALS AND METHODS\u0000We designed a priorities assessment tool using a validated ovarian cancer symptom index (National Comprehensive Cancer Center-Functional Assessment of Cancer Therapy Ovarian Symptom Index-18) combined with an index to assess daily quality-of-life priorities. The tool was distributed to women with ovarian cancer in small focus group settings and online, followed by a postactivity feedback form.\u0000\u0000\u0000RESULTS\u0000In this pilot study, 36 women completed the priorities assessment tool and 35 completed the postactivity feedback form between September 2015 and May 2016. All participants reported that the tool was easy to understand and comprehensive in scope. Twenty-nine participants (82.9%) completed the tool in 10 minutes or less. Most participants (n = 31, 86.1%) were able to stratify their priorities and identify 5 top treatment-related priorities. Participants who indicated that their goals and priorities had changed since diagnosis (n = 25, 69.4%) reported that the tool helped to identify current goals and priorities (22 [88%] of 25 participants) and would help them feel more comfortable participating in shared decision making with their medical team (21 [84%] of 25 participants).\u0000\u0000\u0000CONCLUSION\u0000A patient-centered priorities assessment tool was easy to complete and viewed as comprehensive and useful in a pilot cohort of women with ovarian cancer. Use of a priorities assessment tool has the potential to enhance communication, promote shared decision making, and improve patient satisfaction.","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900455"},"PeriodicalIF":0.0,"publicationDate":"2019-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00455","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44124195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Effect of Medical Scribes on Outpatient Oncology Visits at a Multidisciplinary Cancer Center. 医学抄写员对多学科肿瘤中心肿瘤门诊就诊的影响。
Journal of Oncology Practice Pub Date : 2019-12-05 DOI: 10.1200/JOP.19.00307
Rebecca W. Gao, Anisia Dugala, J. Maxwell, P. Falconer, A. Birkeland, V. Divi, E. Rosenthal
{"title":"Effect of Medical Scribes on Outpatient Oncology Visits at a Multidisciplinary Cancer Center.","authors":"Rebecca W. Gao, Anisia Dugala, J. Maxwell, P. Falconer, A. Birkeland, V. Divi, E. Rosenthal","doi":"10.1200/JOP.19.00307","DOIUrl":"https://doi.org/10.1200/JOP.19.00307","url":null,"abstract":"PURPOSE\u0000The use of medical scribes has emerged as a strategy to increase clinic workflow efficiency and reduce physician burnout. While oncology clinics may be ideally suited to scribe integration because of the high burden of documentation, oncology-specific scribe research has been limited. The objective of this study was to determine the effect of scribe integration on clinic workflow efficiency and physician satisfaction and quality of life in outpatient oncology clinics.\u0000\u0000\u0000METHODS\u0000We conducted a retrospective, concurrent qualitative and quantitative analysis of patient visit durations and survey data for 129 attending physicians affiliated with an academic hospital's cancer center between January 2017 and January 2019. Thirty-three physicians were paired with scribes in each physician's individual clinic or clinics.\u0000\u0000\u0000RESULTS\u0000In terms of clinic efficiency, physicians with scribes had a 12.1% decrease in their overall average patient visit duration compared with their own time before receiving a scribe (P < .0001) and spent significantly less time completing charts at the end of the day (P = .04). Compared with their peers, oncologists with scribes showed a 10%-20% decrease in the duration of all patient visits. Scribes also contributed to patient care, as shown by 90% of physicians surveyed who strongly agreed that they spent less time at the computer and more time with patients; 100% of physicians surveyed strongly agreed that scribes improved their quality of life.\u0000\u0000\u0000CONCLUSION\u0000The integration of medical scribes into oncology clinics across several oncologic disciplines has the potential to reduce burnout through increasing physician satisfaction and quality of life, improving patient care, and streamlining clinic workflow.","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900307"},"PeriodicalIF":0.0,"publicationDate":"2019-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00307","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44975064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Impact of Addition of Carboplatin AUC ≥ 4 to Antiemetic Guidelines for Triple Antiemetic Prophylaxis: A Gap in Quality of Care, Guideline Adoption, and Avoiding Acute Care. 在三重止吐预防的止吐指南中添加卡铂AUC≥4的影响:护理质量、指南采用和避免急性护理方面的差距。
Journal of Oncology Practice Pub Date : 2019-12-04 DOI: 10.1200/JOP.19.00457
R. Navari, K. Ruddy, T. Leblanc, R. Clark-Snow, R. Wickham, G. Binder, T. Coberly, R. Potluri, L. Schmerold, E. Roeland
{"title":"Impact of Addition of Carboplatin AUC ≥ 4 to Antiemetic Guidelines for Triple Antiemetic Prophylaxis: A Gap in Quality of Care, Guideline Adoption, and Avoiding Acute Care.","authors":"R. Navari, K. Ruddy, T. Leblanc, R. Clark-Snow, R. Wickham, G. Binder, T. Coberly, R. Potluri, L. Schmerold, E. Roeland","doi":"10.1200/JOP.19.00457","DOIUrl":"https://doi.org/10.1200/JOP.19.00457","url":null,"abstract":"PURPOSE\u0000After ASCO and National Comprehensive Cancer Network guideline recommendations for triple antiemetic prophylaxis for carboplatin area under the curve (AUC) ≥ 4, and the publication of studies documenting avoidable acute care after chemotherapy involving nausea and vomiting (NV) and other toxicities, we studied clinician adherence to the guideline change and assessed avoidable acute-care use.\u0000\u0000\u0000METHODS\u0000Using a large electronic health record database, we evaluated antiemetic prophylaxis as recommended in the guidelines and post-chemotherapy avoidable acute-care use (defined as involving any of NV or 8 other toxicities) for patients initiating carboplatin or other chemotherapy from October 2012 to August 2018.\u0000\u0000\u0000RESULTS\u0000We identified 11,554 carboplatin courses. After the guideline change adding neurokinin-1 receptor antagonists (RAs) for carboplatin AUC ≥ 4, its use rose to 20% of courses from the prior average of 16%; virtually all courses also included a 5-HT3 RA plus dexamethasone. We found avoidable acute care in 23% of courses; one quarter of these events were associated with NV. Acute care rates after carboplatin mirrored those after other highly emetogenic chemotherapy or oxaliplatin and exceeded those after other chemotherapy regimens. The > 80% shortfall in adherence may have been caused by low awareness or acceptance of the guideline change and/or by poor awareness of avoidable acute-care use after carboplatin.\u0000\u0000\u0000CONCLUSION\u0000Neurokinin-1 RA prophylaxis for carboplatin AUC ≥ 4 remains low and largely unchanged despite National Comprehensive Cancer Network and ASCO 2017 recommendations for inclusion. NV and avoidable acute care involving NV seen after carboplatin were consistent with other highly emetogenic chemotherapy. Clinician action is required to remediate incomplete prophylaxis and to no longer place patient outcomes, resources for cancer treatment, and clinician reimbursement at risk.","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900457"},"PeriodicalIF":0.0,"publicationDate":"2019-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00457","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42306631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Shocking Finding on Head Computed Tomography. 头部计算机断层扫描的惊人发现。
Journal of Oncology Practice Pub Date : 2019-12-03 DOI: 10.1200/jop.19.00275
S. McClelland, T. Mitin
{"title":"Shocking Finding on Head Computed Tomography.","authors":"S. McClelland, T. Mitin","doi":"10.1200/jop.19.00275","DOIUrl":"https://doi.org/10.1200/jop.19.00275","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900275"},"PeriodicalIF":0.0,"publicationDate":"2019-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/jop.19.00275","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47204437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leukemic Infiltration of the Optic Nerve. 白血病性视神经浸润。
Journal of Oncology Practice Pub Date : 2019-12-02 DOI: 10.1200/JOP.19.00311
R. MacDonell-Yilmaz, Brittney Statler, P. Channa, R. Janigian, J. Welch
{"title":"Leukemic Infiltration of the Optic Nerve.","authors":"R. MacDonell-Yilmaz, Brittney Statler, P. Channa, R. Janigian, J. Welch","doi":"10.1200/JOP.19.00311","DOIUrl":"https://doi.org/10.1200/JOP.19.00311","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900311"},"PeriodicalIF":0.0,"publicationDate":"2019-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00311","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43090305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Raynaud's Phenomenon From PD-1 Immune Checkpoint Inhibition. PD-1免疫检查点抑制的雷诺现象。
Journal of Oncology Practice Pub Date : 2019-12-02 DOI: 10.1200/JOP.19.00333
Haesoo Kim, A. J. Jones, Artak Labadzhyan, Veronica R. Placencio-Hickok, D. Wallace, J. Gong, A. Hendifar
{"title":"Raynaud's Phenomenon From PD-1 Immune Checkpoint Inhibition.","authors":"Haesoo Kim, A. J. Jones, Artak Labadzhyan, Veronica R. Placencio-Hickok, D. Wallace, J. Gong, A. Hendifar","doi":"10.1200/JOP.19.00333","DOIUrl":"https://doi.org/10.1200/JOP.19.00333","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900333"},"PeriodicalIF":0.0,"publicationDate":"2019-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00333","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41624452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Foreign Body Mimicking Lung Cancer Recurrence. 异物模拟癌症复发。
Journal of Oncology Practice Pub Date : 2019-12-02 DOI: 10.1200/JOP.19.00394
E. M. Minerva, M. Patella, S. Di Lascio, R. Inderbitzi, S. Cafarotti
{"title":"Foreign Body Mimicking Lung Cancer Recurrence.","authors":"E. M. Minerva, M. Patella, S. Di Lascio, R. Inderbitzi, S. Cafarotti","doi":"10.1200/JOP.19.00394","DOIUrl":"https://doi.org/10.1200/JOP.19.00394","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900394"},"PeriodicalIF":0.0,"publicationDate":"2019-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00394","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45197585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Paraneoplastic Glomerulonephropathy Associated With Renal Cell Carcinoma. 伴肾细胞癌的肿瘤性肾小球肾病。
Journal of Oncology Practice Pub Date : 2019-12-02 DOI: 10.1200/JOP.19.00464
A. Khurana, V. Robila, H. D. Massey, A. Paul
{"title":"Paraneoplastic Glomerulonephropathy Associated With Renal Cell Carcinoma.","authors":"A. Khurana, V. Robila, H. D. Massey, A. Paul","doi":"10.1200/JOP.19.00464","DOIUrl":"https://doi.org/10.1200/JOP.19.00464","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":"1 1","pages":"JOP1900464"},"PeriodicalIF":0.0,"publicationDate":"2019-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00464","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45090414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists. 癌症患者心房颤动和卒中风险:肿瘤学家入门。
Journal of Oncology Practice Pub Date : 2019-12-01 DOI: 10.1200/JOP.18.00592
Marc Sorigue, Milos D Miljkovic
{"title":"Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists.","authors":"Marc Sorigue,&nbsp;Milos D Miljkovic","doi":"10.1200/JOP.18.00592","DOIUrl":"https://doi.org/10.1200/JOP.18.00592","url":null,"abstract":"<p><p>Cancer and atrial fibrillation (AF) are common conditions, but for patients affected with both, there is a lack of data about management of anticoagulation and cerebrovascular outcomes. In the first section of this review, we summarize the most relevant studies on stroke risk and management of AF in patients with active cancer, attempting to answer questions of whether to anticoagulate, whom to anticoagulate, and what agents to use. In the second section of the review, we suggest a decision algorithm on the basis of the available evidence and provide practical recommendations for each of the anticoagulant options. In the third section, we discuss the limitations of the available evidence. On the basis of low-quality evidence, we find that patients with cancer and AF have a risk of stroke similar to that of the general population but a substantially higher risk of bleeding regardless of the anticoagulant agent used; this makes anticoagulation-related decisions complex and evidence from the general population not immediately applicable. In general, we suggest stopping anticoagulation in patients with high risk of bleeding and in those with a moderate bleeding risk without a high thromboembolic risk and recommend anticoagulation as in the general population for patients at a low risk for bleeding. However, regardless of initial therapy, we recommend reassessing whether anticoagulation should be given at each point in the clinical course of the disease. High-quality evidence to guide anticoagulation for AF in patients with cancer is needed.</p>","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":" ","pages":"641-650"},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.18.00592","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37447513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection. 直接抗病毒治疗改善慢性丙型肝炎感染癌症患者的护理和预后的前景
Journal of Oncology Practice Pub Date : 2019-12-01 DOI: 10.1200/JOP.19.00664
Yiannis Koullias, Sarah P Hammond
{"title":"The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection.","authors":"Yiannis Koullias,&nbsp;Sarah P Hammond","doi":"10.1200/JOP.19.00664","DOIUrl":"https://doi.org/10.1200/JOP.19.00664","url":null,"abstract":"","PeriodicalId":54273,"journal":{"name":"Journal of Oncology Practice","volume":" ","pages":"639-640"},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/JOP.19.00664","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37447516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信